Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 13 Urinary Bladder Neoplasms 12 Kidney Neoplasms 7 Carcinoma, Renal Cell 6 Urethral Neoplasms 2 Carcinoma, Transitional Cell 2 Wilms Tumor 1 Urologic Neoplasms 1 Urogenital Neoplasms 1 Testicular Neoplasms 1 Seminoma 1 Prostate Adenocarcinoma 1 Penile Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Muscle Invasive Bladder Cancer 1 Graft vs Host Disease 1 Genomic Instability 1

Interventions

Cisplatin 10 Etoposide 8 Filgrastim 7 Paclitaxel 6 Ifosfamide 6 Carboplatin 6 Bleomycin 5 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 pegfilgrastim 3 Peripheral Blood Stem Cell Transplantation 3 liposomal amphotericin B 2 Therapeutics 2 Platinum 2 Ipilimumab 2 Imatinib Mesylate 2 Cyclophosphamide 2 CTLA-4 Antigen 2 sodium thiosulfate 1 sargramostim 1 lerisetron 1 ixabepilone 1 aldesleukin 1 Vinblastine 1 Thiotepa 1 Sunitinib 1 Specimen Handling 1 Ribavirin 1 Psychiatric Rehabilitation 1 Palivizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Seminoma × Neoadjuvant Therapy × Genitourinary × Clear all

NCT07498959 2026-03-27

TESTIGO

Sahlgrenska University Hospital

Phase NA Recruiting

Testicular Neoplasms, Seminoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡